Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer

NCT06802757 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Posaconazole
DRUG: Nab-paclitaxel
DRUG: Carboplatin
DRUG: Anthracycline
DRUG: Cyclophosphamide
DRUG: PD-1 inhibitors

Sponsor

Shandong Cancer Hospital and Institute